PHARMACOPEIA AND NEUROCRINE EXPAND DRUG DISCOVERY AND DEVELOPMENT COLLABORATION

Pharmacopeia has announced that the Company has extended its ongoing drug discovery and development collaboration with Neurocrine Biosciences Inc. The companies have elected to expand the scope of their collaboration to include an additional disease target against which Pharmacopeia is expected to produce candidates for Neurocrine. Combinatorial Chemistry (http://www.combichem.net/index.aspx?ID=70429)